Is Zepbound stronger than Mounjaro?

No. They contain the same molecule and the strengths overlap; the difference is the approved use.

Why is Mounjaro prescribed for weight loss?

It is the same drug as Zepbound, so some prescribers use it off-label, often for coverage reasons. That is a clinical and insurance decision.

Is Mounjaro the same as Zepbound?

Same active ingredient (tirzepatide). Brands differ by approved indication, labelling and often coverage rules.

Can you switch from Mounjaro to Zepbound?

That is a clinician and insurer decision. This page does not advise switches or dosing.

Mounjaro vs Zepbound: Same Molecule, Different Labels

Mounjaro vs Zepbound: both are tirzepatide — diabetes vs weight-management brands, labels, and user-report links. Not medical advice.

Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →

Short answer

Mounjaro and Zepbound are brand names for the same active ingredient: tirzepatide (a dual GLP-1/GIP agonist). Mounjaro's primary label path is type 2 diabetes; Zepbound's is chronic weight management in eligible adults. Device, indicated population and insurance coding differ even when the molecule matches. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.

Side by side

	Mounjaro	Zepbound
Active ingredient	Tirzepatide	Tirzepatide
Typical label focus	Type 2 diabetes	Chronic weight management
Molecule class	GLP-1 and GIP agonist	GLP-1 and GIP agonist
Sister comparison	vs Ozempic	vs Wegovy

Labels and evidence compared (US)

Last reviewed October 15, 2026.

	Mounjaro	Zepbound
Approved for	Type 2 diabetes (with diet and exercise)	Chronic weight management; moderate-to-severe obstructive sleep apnoea with obesity
Approval year	2022	2023 (sleep apnoea 2024)
Pivotal trials	SURPASS programme	SURMOUNT programme
Forms	Single-dose pens	Single-dose pens and single-dose vials
Insurance coverage	Usually tied to diabetes diagnosis	Depends on obesity coverage
Side effects	Mounjaro side effects	Zepbound side effects

Why two brands exist

Drug approvals are tied to specific uses. Lilly tested tirzepatide separately in diabetes (SURPASS) and in obesity (SURMOUNT) and launched separate brands so labels, pricing and insurer coverage could follow each use. The same pattern exists for semaglutide (Ozempic vs Wegovy). In Canada both brands are authorized and there is still no generic tirzepatide (Zepbound in Canada).

What users report here

#450 (Mounjaro) and #743 (Zepbound) describe similar experiences. Anonymous tirzepatide stories on this site rarely separate the two brand pens cleanly. Start with the tirzepatide side-effects report, Mounjaro side effects and Zepbound side effects. For a different molecule, see Mounjaro vs Ozempic.

More confessions from the archive

Community Q&A

Is Zepbound stronger than Mounjaro?: No. They contain the same molecule and the strengths overlap; the difference is the approved use.
Why is Mounjaro prescribed for weight loss?: It is the same drug as Zepbound, so some prescribers use it off-label, often for coverage reasons. That is a clinical and insurance decision.
Is Mounjaro the same as Zepbound?: Same active ingredient (tirzepatide). Brands differ by approved indication, labelling and often coverage rules.
Can you switch from Mounjaro to Zepbound?: That is a clinician and insurer decision. This page does not advise switches or dosing.
Does this page give dosing advice?: Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.

Sources

Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.